Deferred Tax Assets, Valuation Allowance of Eledon Pharmaceuticals, Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Eledon Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • Eledon Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $46,379,000, a 51% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Eledon Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $46,379,000 +$15,568,000 +51% 31 Dec 2024 10-K/A 14 Aug 2025 2024 FY
Q4 2023 $30,811,000 +$9,136,000 +42% 31 Dec 2023 10-K/A 14 Aug 2025 2024 FY
Q4 2022 $21,675,000 +$9,352,000 +76% 31 Dec 2022 10-K/A 19 Aug 2024 2023 FY
Q4 2021 $12,323,000 +$6,440,000 +109% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $5,883,000 -$5,122,000 -47% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q4 2019 $11,005,000 +$2,994,000 +37% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $8,011,000 +$2,992,000 +60% 31 Dec 2018 10-K 17 Mar 2020 2019 FY
Q4 2017 $5,019,000 +$1,673,000 +50% 31 Dec 2017 10-K 28 Mar 2019 2018 FY
Q4 2016 $3,346,000 -$47,682,000 -93% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $51,028,000 +$17,756,000 +53% 31 Dec 2015 10-K 03 Mar 2017 2016 FY
Q4 2014 $33,272,000 +$8,870,000 +36% 31 Dec 2014 10-K 03 Mar 2017 2016 FY
Q4 2013 $24,402,000 +$6,264,000 +35% 31 Dec 2013 10-K 03 Mar 2017 2016 FY
Q4 2012 $18,138,000 +$4,009,000 +28% 31 Dec 2012 10-K 10 Mar 2016 2015 FY
Q4 2011 $14,129,000 31 Dec 2011 10-K 26 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.